Cargando…
Re-emerging threat of Trypanosoma cruzi vector transmission in El Salvador, update from 2018 to 2020
BACKGROUND: Since the late twentieth century, Chagas disease gained global attention to suppress the vector burden as a main control strategy in endemic countries. In Central America, multi-national initiative successfully achieved significant reduction in the estimated disease prevalence as well as...
Autores principales: | Rodríguez, Marvin Stanley, Nitahara, Yuko, Cornejo, Michelle, Siliezar, Kevin, Grande, Rafael, González, Ana, Tasaki, Kotaro, Nakagama, Yu, Michimuko, Yu, Onizuka, Yoko, Nakajima-Shimada, Junko, Romero, José Eduardo, Palacios, José Ricardo, Arias, Carmen Elena, Mejía, William, Kido, Yasutoshi, Cardona Alvarenga, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361614/ https://www.ncbi.nlm.nih.gov/pubmed/35945552 http://dx.doi.org/10.1186/s40249-022-01008-5 |
Ejemplares similares
-
Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America
por: Nakagama, Yu, et al.
Publicado: (2022) -
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients
por: Nitahara, Yuko, et al.
Publicado: (2021) -
A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity
por: Nakagama, Yu, et al.
Publicado: (2022) -
Inflammatory cardiomyopathy of possibly overlapping aetiology: a case posing treatment dilemma and potential association
por: Nakagama, Shun, et al.
Publicado: (2021) -
Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response
por: Nakagama, Sachie, et al.
Publicado: (2023)